For the recognized Ministry of Defense disabled veterans. In accordance with the indications approved by the Israeli Ministry of Health. The use of the Inhaler is subject to the recommendation of a physician and a license for the use of medical cannabis by the Israeli Ministry of Health, in accordance with the requirements of the law. Clinically-validated. This is not a medical recommendation. For licensees for inflorescences types T20C4, T10C2, T15C3, or for Sativa T20C4 type cartridges for Inhaler.
*Compared to the other routes of administration.
Almog S, et al. (2020). European Journal of Pain, 24(8), 1505-1516.
Aviram J. et al. (2022). PAIN Reports. 7(3), e1011.
Aviram J. et al. (2021). European Journal of Pain, 25(2), 359-374.
Metered-Dose Inhaler & Medical Cannabis Cartridges
100% FUNDING FOR DISABLED
SECURITY FORCES VETERANS
SECURITY FORCES VETERANS
100% FUNDING FOR DISABLED SECURITY FORCES VETERANS
No need to pay and wait for refunds!
Home delivery - free of charge
Free nursing guidance & support
Home delivery - free of charge
Free nursing guidance & support
Fast reduction in the intensity of chronic neuropathic pain, with minimum side effects*, to improve quality of life
The SyqeAir Inhaler is intended for use with the SyqeAir Cartridge only. No other cannabis inflorescence or oil can be inserted into the Cartridge.
The SyqeAir Inhaler is intended for use with the SyqeAir Cartridge only. No other cannabis inflorescence or oil can be inserted into the Cartridge.
For the recognized Ministry of Defense disabled veterans. In accordance with the indications approved by the Israeli Ministry of Health. The use of the Inhaler is subject to the recommendation of a physician and a license for the use of medical cannabis by the Israeli Ministry of Health, in accordance with the requirements of the law. Clinically-validated. This is not a medical recommendation. For licensees for inflorescences types T20C4, T10C2, T15C3, or for Sativa T20C4 type cartridges for Inhaler.
*Compared to the other routes of administration.
Almog S, et al. (2020). European Journal of Pain, 24(8), 1505-1516.
Aviram J. et al. (2022). PAIN Reports. 7(3), e1011.
Aviram J. et al. (2021). European Journal of Pain, 25(2), 359-374.
